News

Novo Nordisk CEO's surprise exit after setbacks in weight-loss market: Reaction
Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...
Novo Nordisk CEO's surprise exit after setbacks in weight-loss market
Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...
Instant View: Novo Nordisk CEO's surprise exit after setbacks in weight-loss market
Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...
Novo Nordisk CEO steps down in surprise move as 'market challenges' weigh on obesity drugmaker
Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down after eight years in the role, during which he led the company to an all-time high in the markets. Despite being the f ...
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company's ...
pharmaphorum1d
TauRx sees path to FDA filing for tau-targeting Alzheimer's drug
Because the drug changes the colour of urine, patients would know if they were in the active arm of the study if a regular placebo was used. As a result, TauRx opted to use methylthioninium ...